LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS

APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTORS AND CHANGE OF COMPOSITION OF BOARD COMMITTEES

POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 17 JUNE 2026

NEXT DAY DISCLOSURE RETURN

VOLUNTARY ANNOUNCEMENT - DATA FROM PHASE II CLINICAL TRIAL OF TQC2938 “ST2 MONOCLONAL ANTIBODY” PRESENTED AT EAACI 2026

SHARE PURCHASE PLAN FOR AN AGGREGATE AMOUNT OF NOT EXCEEDING HK$2 BILLION

NEXT DAY DISCLOSURE RETURN

VOLUNTARY ANNOUNCEMENT - DATA FROM PHASE II CLINICAL TRIAL OF CULMERCICLIB “CDK2/4/6 INHIBITOR” IN CDK4/6 INHIBITOR-PRETREATED PATIENTS PRESENTED AT 2026 ASCO